Skip to main content

CORRECTION article

Front. Immunol., 07 February 2023
Sec. Vaccines and Molecular Therapeutics
Volume 14 - 2023 | https://doi.org/10.3389/fimmu.2023.1151809

Corrigendum: Differential biodistribution of adenoviral-vectored vaccine following intranasal and endotracheal deliveries leads to different immune outcomes

This article is a correction to:

  1. Differential Biodistribution of Adenoviral-Vectored Vaccine Following Intranasal and Endotracheal Deliveries Leads to Different Immune Outcomes

    1. Read original article
Vidthiya Jeyanathan,Vidthiya Jeyanathan1,2Sam Afkhami,Sam Afkhami1,2Michael R. D&#x;Agostino,Michael R. D’Agostino1,3Anna Zganiacz,Anna Zganiacz1,2Xueya Feng,Xueya Feng1,2Matthew S. Miller,Matthew S. Miller1,3Mangalakumari Jeyanathan,Mangalakumari Jeyanathan1,2Michael R. ThompsonMichael R. Thompson4Zhou Xing,*Zhou Xing1,2*
  • 1McMaster Immunology Research Centre, M. G. DeGroote Institute for Infectious Disease Research, Hamilton, ON, Canada
  • 2Department of Medicine, McMaster University, Hamilton, ON, Canada
  • 3Department of Biochemistry & Biomedical Sciences, McMaster University, Hamilton, ON, Canada
  • 4Department of Chemical Engineering, McMaster University, Hamilton, ON, Canada

A Corrigendum on
Differential biodistribution of adenoviral-vectored vaccine following intranasal and endotracheal deliveries leads to different immune outcomes

By Jeyanathan V, Afkhami S, D’Agostino MR, Zganiacz A, Feng X, Miller MS, Jeyanathan M, Thompson MR and Xing Z (2022) 13:860399. doi: 10.3389/fimmu.2022.860399

In the published article, an author name was incorrectly written as “Vidthiya Jeyananthan”. The correct spelling is “Vidthiya Jeyanathan”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: respiratory mucosal immunization, intranasal, endotracheal, biodistribution, Adenovirus-vectored vaccine, Tuberculosis, mucosal immunity, T cells

Citation: Jeyanathan V, Afkhami S, D’Agostino MR, Zganiacz A, Feng X, Miller MS, Jeyanathan M, Thompson MR and Xing Z (2023) Corrigendum: Differential biodistribution of adenoviral-vectored vaccine following intranasal and endotracheal deliveries leads to different immune outcomes. Front. Immunol. 14:1151809. doi: 10.3389/fimmu.2023.1151809

Received: 26 January 2023; Accepted: 27 January 2023;
Published: 07 February 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Jeyanathan, Afkhami, D’Agostino, Zganiacz, Feng, Miller, Jeyanathan, Thompson and Xing. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Zhou Xing, xingz@mcmaster.ca

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.